Login to Your Account

Clinic Roundup

Monday, December 20, 2010
Inspire Pharmaceuticals Inc., of Durham, N.C., said findings published in the American Journal of Respiratory and Critical Care Medicine showed that cystic fibrosis patients, age 5 and older, receiving inhaled denufosol had better lung exhalation rates than those in the placebo group at the end of 24 weeks in a Phase III trial.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription